Taiki Hakozaki

11PUBLICATIONS
10CO-AUTHORS
ChiropracticPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 12, 2026
Capturing durable benefits: interpreting six-year treatment-free survival and restricted mean survival time in CheckMate 227.

Takayuki Kobayashi, Shohei Nakamura, Taiki Hakozaki

|Feb 20, 2025
Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection.

Takahiro Sugawara, Taiki Hakozaki, Masahiro Seike

|Nov 30, 2023
Prognostic significance of initial tumor shrinkage in patients with stage III non-small cell lung cancer treated with durvalumab following chemoradiotherapy.

Yuto Terashima, Taiki Hakozaki, Yuji Uehara

|Nov 24, 2023
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer.

Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy

|Nov 11, 2022
Cancer Cachexia among Patients with Advanced Non-Small-Cell Lung Cancer on Immunotherapy: An Observational Study with Exploratory Gut Microbiota Analysis.

Taiki Hakozaki, Alexis Nolin-Lapalme, Masato Kogawa

|Oct 17, 2022
Lenvatinib rechallenge in a patient with advanced thymic carcinoma: A case report.

Yuto Terashima, Taiki Hakozaki, Susumu Takeuchi

Pageof 2

Frequent Collaborators

4 joint publications

Yusuke Okuma

4 joint publications

Yukio Hosomi

2 joint publications

Yuji Uehara

1 joint publications

Lisa Derosa